Fermentate Of Unknown Chemical Structure Patents (Class 424/115)
  • Patent number: 10264796
    Abstract: A method for producing a seed of a plant resistant to seedling diseases is provided which includes contacting a non-pathogenic microbe corresponding to a seed-borne pathogen with a flower part of a host plant around the flowering time and collecting a seed of the host plant colonized by the non-pathogenic microbe obtained thereafter, and a method for controlling seedling diseases using the seed.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: April 23, 2019
    Assignee: NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY
    Inventors: Tsutomu Arie, Tohru Teraoka, Youko Nonaka, Akihiro Kato, Jun Tanaka, Tomomi Tokunaga, Kenichi Kurauchi, Tomotaka Suzuki
  • Patent number: 10265368
    Abstract: A method of treating or preventing bacterial infection in an animal comprises administering an effective amount of degraded date pits. Degraded date pits can be produced by the treatment of date pits with fungi.
    Type: Grant
    Filed: April 11, 2017
    Date of Patent: April 23, 2019
    Assignee: United Arab Emirates University
    Inventors: Ahmed Soliman Hussein, Ibrahim Hassan Belal, Salem Rashed Ali Alyalyali, Khaled Abas El Tarabily
  • Patent number: 10219517
    Abstract: The present invention relates to the Bacillus sp. strains AT-332 (NITE BP-1095) and AT-79 (NITE BP-1094) isolated from nature; and a plant disease control agent, a nematode control agent and a plant growth promoter containing the strains as active bacteria. The Bacillus sp. strains AT-332 and AT-79 strain are effective in controlling both a wide range of various plant diseases and nematode-damage and capable of promoting the growth of useful plants, due to a culture containing a secondary metabolite of the strains or cultivated and isolated live bacteria of the strains being introduced to a plant body or to the culture soil.
    Type: Grant
    Filed: October 17, 2016
    Date of Patent: March 5, 2019
    Assignee: SDS BIOTECH K.K.
    Inventors: Yusuke Amaki, Keijitsu Tanaka, Motoki Tanaka, Akitomo Takahashi
  • Patent number: 10206961
    Abstract: Compositions comprising metabolized conditioned growth medium and/or metabolized cell extract and methods of use are described. The metabolized conditioned growth medium and metabolized cell extract compositions may be formulated with an acceptable carrier into injectable or topical formulations, for example, as a cream, lotion or gel, and may be used in cosmeceutical or pharmaceutical applications. The metabolized conditioned growth medium and metabolized cell extract may also be further processed to concentrate or reduce one or more factors or components contained within the metabolized conditioned growth medium or metabolized cell extract. The growth medium may be conditioned by any eukaryotic cell. The metabolized conditioned growth medium and metabolized cell extract may be used to prevent or treat a condition, for example, a skin condition.
    Type: Grant
    Filed: October 7, 2013
    Date of Patent: February 19, 2019
    Assignee: Allergan, Inc.
    Inventors: James Vincent Gruber, Smitha Rao, Rahul Mehta, Sujatha D. Sonti
  • Patent number: 10111439
    Abstract: The present invention is directed to non-aqueous, non-oil liquid compositions comprising Bacillus amyloliquefaciens and a liquid carrier. The present invention is further directed methods of controlling nematodes comprising applying an effective amount of a non-aqueous, non-oil liquid composition comprising Bacillus amyloliquefaciens and a liquid carrier to an area in need of nematode control.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: October 30, 2018
    Assignee: VALENT BIOSCIENCES LLC
    Inventors: Zhengyu Huang, Benjamin A. Belkind, Venkat Gangavarapu, Zuoxing Zheng, Todd James Mayhew, Ana Vida C. Alcala
  • Patent number: 10046014
    Abstract: The present invention relates to the cosmetic use of a lysate of a bacterium or bacteria belonging to the Vitreoscilla sp. genus (in particular the species: Vitreoscilla filiformis) in a complete fermentation medium, as an active agent for preventing and/or treating dandruff conditions of the scalp, including dandruff conditions of the scalp associated with a prevalence of pathogenic microorganisms on the scalp and/or an imbalance of the scalp ecoflora.
    Type: Grant
    Filed: April 5, 2012
    Date of Patent: August 14, 2018
    Assignee: L'OREAL
    Inventors: Pascal Hilaire, Yann Mahe, Richard Martin
  • Patent number: 9993004
    Abstract: A method for increasing the vigor and/or crop yield of agricultural plants under essentially non-existent pathogen pressure, wherein the plants, the plant propagules, the seed of the plants and/or the locus where the plants are growing or are intended to grow are treated with an effective amount of a composition comprising a) the Bacillus subtilis strain with NRRL Accession No. B-21661 or a cell-free extract thereof, and/or a mutant of this strain or extract having all the identifying characteristics of the respective strain or extract as component (I), and b) optionally at least one chemical compound as component (II), selected from the active compound groups A) to J): A) strobilurins; B) carboxamides; C) azoles; D) heterocyclic compounds; E) carbamates; F) other active substances; G) growth regulators; H) herbicides; J) insecticides.
    Type: Grant
    Filed: March 18, 2015
    Date of Patent: June 12, 2018
    Assignee: Bayer CropScience LP
    Inventors: Markus Frank, David Ernest Silva
  • Patent number: 9918982
    Abstract: Dosage forms and drug delivery devices suitable for administration of pharmaceutical compounds and compositions, including the oral drug administration of compounds.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: March 20, 2018
    Assignee: Durect Corporation
    Inventors: Su Il Yum, Grant Schoenhard, Arthur J. Tipton, John W. Gibson, John C. Middleton, Roger Fu, Michael S. Zamloot
  • Patent number: 9801842
    Abstract: The present invention relates to methods and compositions for treating pulmonary infection. In particular, the present invention provides nanoemulsion compositions and methods of using the same to treat bacteria associated with biofilms (e.g., found in pulmonary infections). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: October 31, 2017
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: James R. Baker, Jr., Sivaprakash Rathinavelu, Paul E. Makidon, John J. LiPuma, Shraddha Nigavekar
  • Patent number: 9795138
    Abstract: The present invention relates to a method for increasing the vigor and/or crop yield of agricultural plants under essentially non-existent pathogen pressure, wherein the plants, the plant propagules, the seed of the plants and/or a locus where the plants are growing or are intended to grow are treated with an effective amount of a composition comprising a Bacillus subtilis strain with NRRL Accession No. B-21661, a mutant of the strain having all the identifying characteristics of the strain, or a cell-free extract thereof; and a compound selected from the group consisting of fosetyl, fosetyl-aluminum, propamocarb, and propamocarb hydrochloride; wherein the vigor and/or crop yield of agricultural plants under essentially non-existent pathogen pressure is increased.
    Type: Grant
    Filed: March 18, 2015
    Date of Patent: October 24, 2017
    Assignee: Bayer CropScience LP
    Inventors: Markus Frank, David Ernest Silva
  • Patent number: 9795572
    Abstract: Methods of shortening the duration of anti-infective therapy and increasing the effectiveness of anti-infective drugs in subjects with infection are present. The methods are based on altering the replication rate of a pathogen, which makes the pathogen more susceptible to the actions of the anti-infective drug.
    Type: Grant
    Filed: January 26, 2016
    Date of Patent: October 24, 2017
    Assignee: INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.
    Inventor: Paul G. Ambrose
  • Patent number: 9771284
    Abstract: Embodiments of the invention provide for treating arsenic contaminants in an in situ environment. In accordance with an embodiment of the invention, a stabilized oxidizing agent can be prepared, for instance a stabilized liquid hydrogen peroxide agent, as can an aqueous chelated iron solution. Both the stabilized oxidizing agent and the aqueous chelated iron solution can be alternately introduced into the in situ environment contaminated with arsenic by way of alternate injection screens into the in situ environment so as to remediate the arsenic contamination of the in situ environment.
    Type: Grant
    Filed: December 30, 2013
    Date of Patent: September 26, 2017
    Assignee: ENVIRONMENTAL TECHNOLOGY AND INVESTMENT CORPORATION
    Inventor: Stan Charles Haskins
  • Patent number: 9597345
    Abstract: The invention relates to a kit-in-part comprising of a composition for the use as a cleaning and treating of ears of a companion animal and suitable packaging material, wherein the kit-in part additionally consists of components selected from the group of a pharmaceutical composition for use in the treatment of otitis externa, application and dosage information, cannules, cotton swabs, gauzes and information about the cleaning and maintenance ears of a companion animal.
    Type: Grant
    Filed: December 21, 2011
    Date of Patent: March 21, 2017
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Joachim Karle, Reinhard Seffner
  • Patent number: 9591867
    Abstract: The invention relates to compositions comprising abscisic acid, and/or salts, derivatives and analogs thereof, and methods of using the same for improving the health and survival of animal offspring.
    Type: Grant
    Filed: August 20, 2014
    Date of Patent: March 14, 2017
    Assignee: Valent BioSciences Corporation
    Inventors: Maria Pilar Herrero, Warren E. Shafer
  • Patent number: 9572774
    Abstract: Dry powder vancomycin compositions and methods for administering and preparing such compositions are provided.
    Type: Grant
    Filed: November 19, 2013
    Date of Patent: February 21, 2017
    Assignee: SAVARA INC.
    Inventors: John Lord, Jaakko Taneli Jouhikainen, Herman E. Snyder, Pravin Soni, Mei-Chang Kuo
  • Patent number: 9549914
    Abstract: The present invention relates to the field of virology. More specifically, the present invention provides methods and compositions useful for treating human cytomegalovirus using Wnt pathway modulators. In a specific embodiment, a method for treating human cytomegalovirus (HCMV) in a patient in need thereof comprises administering an effective amount of Wnt pathway modulator.
    Type: Grant
    Filed: April 3, 2015
    Date of Patent: January 24, 2017
    Assignee: The Johns Hopkins University
    Inventor: Ravit Boger
  • Patent number: 9457054
    Abstract: The present invention relates to a method for enhancing the health of a human comprising administering to the human an effective amount of a composition comprising Bacillus subtilis QST713 or a mutant thereof.
    Type: Grant
    Filed: March 17, 2011
    Date of Patent: October 4, 2016
    Assignee: Bayer CropScience LP
    Inventors: Joseph Earl Schmidt, Desmond Rito Jimenez
  • Patent number: 9446075
    Abstract: Compositions for use in treatment of a variety of tissue diseases include stem cells and stem cell released molecules (SRM's) suspended in an aqueous solution with a cellulosic material or other thickening agent. The stem cells and SRM's can be derived from one or more distinct cell lines. The SRM's can further include one or more mucins, cytokines, or growth factors. Exemplary formulations include stem cells and SRMs derived from epithelial stem cells, corneal limbal stem cells, and fibroblasts. Other compositions and methods for formulation thereof are described.
    Type: Grant
    Filed: March 18, 2014
    Date of Patent: September 20, 2016
    Assignee: BioRegenerative Sciences
    Inventor: Greg Maguire
  • Patent number: 9314496
    Abstract: This invention provides a product safe for treating, improving or preventing an inflammatory bowel disease such as ulcerative colitis, and provides a product comprising an insoluble dietary fiber obtained by enzymatic treatment of seeds of a grain plant(s) or germinated young seeds thereof, as well as a food or drink or medicament comprising the product.
    Type: Grant
    Filed: December 19, 2008
    Date of Patent: April 19, 2016
    Assignee: KIRIN HOLDINGS KABUSHIKI KAISHA
    Inventors: Hideo Ohmae, Hiroshi Murayama, Naohiro Takimoto, Yuji Sakamoto, Osamu Kanauchi, Mikio Katayama, Hiroyuki Watanabe, Yuta Komano
  • Patent number: 9238059
    Abstract: The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: January 19, 2016
    Assignee: Hybrid Medical, LLC
    Inventors: Jeff Twidwell, Joel Buckley, Harold Hoium
  • Patent number: 9206212
    Abstract: Novel actinomycete strain composition and its use.
    Type: Grant
    Filed: July 20, 2012
    Date of Patent: December 8, 2015
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE CADI AYYAD-FACULTE DES SCIENCES SEMLALIA, MARRAKECH-MAROC
    Inventors: Marie-Joëlle Virolle, Hanane Hamdali, Yedir Ouhdouch, Mohamed Hafidi, Ahmed Benharref, Ahmed Lebrihi, Marie Carmen Monje
  • Patent number: 9175258
    Abstract: The present invention comprises compositions and methods for enhancing biological processes, such as plant growth or bioremediation. For example, the present invention comprises compositions and methods for effectively remediating chemical and organic wastes and reducing the environmental risk from manure, septic, sewage, oil pollution, and other contaminants.
    Type: Grant
    Filed: January 12, 2012
    Date of Patent: November 3, 2015
    Assignee: Inocucor Technologies, Inc.
    Inventors: Margaret Bywater-Ekegard, Ananda Fitzsimmons
  • Patent number: 9161930
    Abstract: The invention relates to application of 4,4?-diphenylmethane-bis(methyl) carbamates (DPMC) extracted and isolated from Cortex Mori and preparation of medicine for diabetic nephropathy. The pharmaceutical composition is made up of DPMC as active ingredient and the normal drug carriers, and the weight percentage of active ingredient is 0.1-99.5%. For the remarkable effect of prevention and cure for diabetic nephropathy and convenience for use, it will be a new facultative drug for patients.
    Type: Grant
    Filed: November 2, 2011
    Date of Patent: October 20, 2015
    Assignee: Guangzhou Consun Medicine R & D Co., Ltd.
    Inventors: Quan Zhu, Xinghua Shi, Dan Tang, Zhaoguang Zheng, Bao He, Tingting Duan, Fei Gu, Huiquan Cheng, Xiaoling Huang, Yanxia Huang, Rushang Wang
  • Patent number: 9125934
    Abstract: Sensitive skin, mucous membranes and scalps are treated by administering to individuals in need of such treatment, thus effective amounts of at least one extract of a non-photosynthetic and non-fruiting filamentous bacterium cultured in a medium which includes at least one non-sulfurous mineral and/or thermal water, e.g., an extract derived from the bacterium Vitreoscilla filiformis, in particular the strain ATCC 15551, cultured in a medium enriched with water from La Roche Posay.
    Type: Grant
    Filed: July 17, 2008
    Date of Patent: September 8, 2015
    Assignee: L'Oreal
    Inventors: Lionel Breton, Yann Mahe, Richard Martin
  • Publication number: 20150139978
    Abstract: The present invention relates to a novel monascuspurpurone compound of formula (I): or a pharmaceutically acceptable derivative thereof as described in the specification, the process for preparation of the same, and the composition comprising the same. The uses of a monascuspurpurone compound for promoting adipocyte differentiation, for increasing the activity of PPAR? and/or C/EBP?, for lowering blood glucose, for preventing and/or treating a disease or disorder related to insulin resistance, and for preventing and/or treating metabolic syndrome or its complications are also provided.
    Type: Application
    Filed: October 9, 2014
    Publication date: May 21, 2015
    Inventors: Ming-Jen Cheng, Ping-Hsun Yang, Ming-Der Wu, Shie-Jea Lin, Gwo-Fang Yuan, Yen-Lin Chen, Hsuen-Chun Liao, Kai-Ping Chen
  • Publication number: 20150140098
    Abstract: The invention relates to the use of feed material comprising grain and Agaricus Blazei, comprising the Agaricus species in an amount between 10 to 50% by weight on dry matter, and the feed material having a moisture content of less than 10% (relative to dry matter), for administration to chicken for improvement of egg laying, preferably for improving shell quality and/or for extending the egg laying period. The invention further relates to a process for making the feed material, and feed for laying hens comprising the feed material.
    Type: Application
    Filed: May 14, 2013
    Publication date: May 21, 2015
    Applicant: SSIPfeed B.V.
    Inventors: Wilhelmus Hubertus Henricus Antonius Van Den Elshout, Pierre Michel Grammare
  • Publication number: 20150139958
    Abstract: Provided are a feed composition, which can be stored for a long time and is easily produced and adjustable in components, and which can increase the body weight and reduce a feed conversion ratio of farm animals to which the feed composition is fed, and a production method for the feed composition. In the feed composition, a liquid feed additive obtained by fermenting a carbohydrate-containing carbohydrate raw material by Aspergillus is substituted for 5 to 50% on a dry matter basis of a feed raw-material.
    Type: Application
    Filed: July 16, 2013
    Publication date: May 21, 2015
    Inventor: Masahiro Yamamoto
  • Patent number: 9023347
    Abstract: The invention relates to relatively light and thermally stable granulated, fermentation-broth-based animal feed additives having a high content of L-lysine and to low-loss methods for their production from broths obtained by fermentation.
    Type: Grant
    Filed: June 18, 2014
    Date of Patent: May 5, 2015
    Assignee: Evonik Degussa GmbH
    Inventors: Hermann Lotter, Ulrich Becker, Frank Dübner, Friederike Kaeppke, Joachim Pohlisch, Ralf Kelle, Cory M. Sander, Lawrence Edward Fosdick
  • Publication number: 20150118220
    Abstract: The present invention relates to food for nutritional therapy of AIDS belonging to functional foods. It is made from deep fermentation of Morchella spp and Tricholoma matsutake in traditional Chinese medicine medium extracting from Callicarpa bodinieri. The combination and synergistic effect of the food components could alleviate fear of chill caused by large number of broken erythrocyte in patients with AIDS, improve immunity effectively, ameliorate symptoms and physical signs, promote body activities, further postpone complication occurrence and improve patient's quality of life.
    Type: Application
    Filed: April 26, 2013
    Publication date: April 30, 2015
    Inventors: Du PENG, Jianjiang SI
  • Publication number: 20150098934
    Abstract: Topical compositions comprising grape seed and at least three of folic acid, biotin, Bifidobacterium longum extract and Echinacea purpurea.
    Type: Application
    Filed: October 3, 2013
    Publication date: April 9, 2015
    Inventors: Wilson A. Lee, Edward Pelle, Nadine A. Pernodet, Barbara A. Crockett, Georgena M. Keupp
  • Patent number: 8968729
    Abstract: A method of treating or preventing bacterial infection in an animal comprises administering an effective amount of degraded date pits. Degraded date pits can be produced by the treatment of date pits with fungi.
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: March 3, 2015
    Assignee: United Arab Emirates University
    Inventors: Ahmed Soliman Hussein, Ibrahim Hassan Belal, Salem Rashed Ali Alyalyali, Khaled Abas El-Tarabily
  • Patent number: 8961963
    Abstract: Disclosed is a pharmaceutical natural composition containing both statin compounds (mevinolin and mevinolinic acid) serving as cholesterol biosynthesis inhibitors and coenzyme Q (ubiquinone-10: CoQ10 and ubiquinone-9: CoQ9) compounds which are substances that inhibit factors causing complications such as myalgia involved in long-term use of the statin, prepared using Monascus sp. and natural medicinal substances such as ginseng, mushrooms and cereals.
    Type: Grant
    Filed: December 28, 2009
    Date of Patent: February 24, 2015
    Assignee: Sungshin Women's University Industry-Academic Cooperation Foundation
    Inventor: Young-Hee Pyo
  • Publication number: 20150044188
    Abstract: Molecules secreted or derived from probiotic bacteria are provided for use in compositions and methods for the treatment and/or prevention of infection by pathogenic viruses. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal.
    Type: Application
    Filed: August 12, 2014
    Publication date: February 12, 2015
    Inventor: Mansel Griffiths
  • Publication number: 20150023908
    Abstract: The present invention relates to skin care compositions, including cosmeceuticals, for topical application, and more particularly, a skin cream, comprising exosomes and cell culture medium conditioned by cells grown in two-dimensional culture. Also included are methods of making and using such compositions and kits comprising the skin cream therein.
    Type: Application
    Filed: July 18, 2013
    Publication date: January 22, 2015
    Inventor: Ahmed H. Al-Qahtani
  • Publication number: 20150017152
    Abstract: A composition comprising 4-oxovaleric acid present in an amount of 0.05 to 1% by weight (as supplied) of the composition and leuconostoc/radish root ferment filtrate present at 0.2 to 2% by weight (as supplied) of the composition.
    Type: Application
    Filed: October 1, 2014
    Publication date: January 15, 2015
    Inventors: Kathy Potechin, Christine Boyke
  • Publication number: 20140335073
    Abstract: A nutritional composition comprising a combination of non-digestible oligosaccharides and a product obtained by incubating an aqueous substrate by bifidobacteria and optionally a product obtained by incubating an aqueous substrate by S. thermophilus. Said combination reduces bacterial translocation and improves the intestinal barrier function.
    Type: Application
    Filed: March 7, 2014
    Publication date: November 13, 2014
    Applicant: N.V. Nutricia
    Inventors: Jan KNOL, Cornelus Johannes Petrus VAN LlMPT, Francis LE CROIX, Valérie PETAY
  • Patent number: 8877184
    Abstract: A cleansing composition comprising surfactants comprising decyl glucoside and coco glucoside, wherein the decyl glucoside is present in an amount by weight that is 1.5 to 2.5 times the weight of coco glucoside.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: November 4, 2014
    Assignee: Colgate-Palmolive Company
    Inventors: Kathy Potechin, Christine Boyke
  • Publication number: 20140308268
    Abstract: A detergent composition includes an alcoholic beverage, a moisturizer, a surfactant and water; and the surfactant is a natural coconut oil foaming agent. By including the alcoholic beverage, the detergent composition does not need any addition of a preserving agent and provides additional disinfecting effect as well as upgraded cleansing effect.
    Type: Application
    Filed: December 11, 2013
    Publication date: October 16, 2014
    Inventor: Wen-Chen WEI
  • Publication number: 20140308265
    Abstract: The claimed invention is directed to compositions and methods effective in preventing microbial contamination or reducing microbial count associated with a contaminated surface, comprising a biocidal system comprised of a primary biocide, a pH buffer agent, a surfactant, all in an aqueous based carrier, wherein the compositions may be considered environmentally friendly.
    Type: Application
    Filed: November 6, 2012
    Publication date: October 16, 2014
    Inventors: Burt R. Sookram, John W. Veenstra
  • Publication number: 20140271586
    Abstract: The present disclosure relates to nutritional compositions including a protein equivalent source that includes a peptide component comprising selected peptides. The protein equivalent source may further include intact protein, hydrolyzed protein, including partially hydrolyzed protein, or combinations thereof. The disclosure further relates to methods of promoting healthy body weight in a target subject by stimulating adiponectin levels by providing the nutritional compositions disclosed herein to a target subject, which includes a pediatric subject.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: Mead Johnson Nutrition (Asia Pacific) Pte. Ltd.
    Inventors: DIRK HONDMANN, ERIC A.F. VAN TOL, GABRIELE GROSS, MARIEKE H. SCHOEMAKER, TEARTSE TIM LAMBERS
  • Publication number: 20140271552
    Abstract: The present disclosure relates to nutritional compositions including a protein equivalent source including a peptide component comprising selected peptides from Tables 1 and 2 disclosed herein. The protein equivalent source may further include intact protein, hydrolyzed protein, including partially hydrolyzed protein, or combinations thereof. The disclosure further relates to methods of reducing the incidence of autoimmune disease and/or diabetes mellitus by providing said nutritional compositions to a target subject, which includes a pediatric subject.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Inventors: Dirk Hondmann, Eric A.F. van Tol, Gabriele Gross, Marieke H. Schoemaker, Teartse Tim Lambers
  • Publication number: 20140255385
    Abstract: Disclosed herein is that an active ingredient obtained from cultivation of Cordyceps militaris can be used in the treatment of glioblastoma.
    Type: Application
    Filed: March 5, 2013
    Publication date: September 11, 2014
    Applicant: I SHOU UNIVERSITY
    Inventors: Chih-Hui YANG, Keng-Shiang HUANG, Ya-Hui HSIEH
  • Publication number: 20140242066
    Abstract: The present invention relates to composition comprising Lactobacillus rye ferment, dialkylisosorbide and phospholipid. Preferably, the composition further comprises ethoxylated sorbitan fatty acid ester. The composition has been shown to be effective against infections of closed comedones. The invention further relates to a method of preparing the composition, to a roll-on applicator comprising the composition and to the use of the composition in treatment of closed comedones infections.
    Type: Application
    Filed: September 20, 2012
    Publication date: August 28, 2014
    Inventor: Elzbieta Ewa Brand-Garnys
  • Patent number: 8802408
    Abstract: The present invention relates to a process for preparing a nutritional, therapeutic or organoleptic product by growing non-recombinant yeast under aerobic conditions, in a medium that includes crude glycerol, as one possible carbon source to produce a yeast product. The yeast product can be processed to obtain such nutritional, therapeutic or organoleptic products as yeast paste, yeast metabolites, carbohydrates, proteins, functional proteins, nucleotides, yeast autolysates, yeast extract, yeast cell walls, beta-glucans, mannans or a product derived from a mineralized yeast product.
    Type: Grant
    Filed: January 16, 2009
    Date of Patent: August 12, 2014
    Assignee: Bio Processing Australia Pty Ltd.
    Inventors: Robin Fieldhouse, Donald Finlay MacLennan, David Graham MacLennan, Mary Elizabeth MacLennan
  • Publication number: 20140219993
    Abstract: A virus infection inhibitor containing a fermentation by-product such as an amino acid fermentation by-product and a nucleic acid fermentation by-product is sprinkled onto a plant body of a plant, such as tobacco, tomato, bell pepper, and chili pepper to control a disease induced by infection of a virus such as Tobamovirus viruses and Cucumovirus viruses.
    Type: Application
    Filed: April 11, 2014
    Publication date: August 7, 2014
    Applicant: AJINOMOTO CO., INC.
    Inventors: Reiko Tomita, Naoki Kadotani, Kentaro Sekine
  • Publication number: 20140223609
    Abstract: Embodiments of the present invention relate to insecticidal Bacillus thuringiensis Cry1 and Cry2 polypeptides. Methods for using the polypeptides and nucleic acids of embodiments of the invention to synergistically enhance resistance of plants to insect predation are encompassed in embodiments of the present invention.
    Type: Application
    Filed: April 16, 2014
    Publication date: August 7, 2014
    Applicants: E I DU PONT DE NEMOURS AND COMPANY, PIONEER HI BRED INTERNATIONAL INC
    Inventors: John Lindsey Flexner, Deirdre Kapka-Kitzman, Lisa Procyk, Bruce H. Stanley, Jianzhou Zhao
  • Publication number: 20140186331
    Abstract: The present invention provides a body weight gain suppressing composition including an ?-glucosidase activity inhibitor component, preferably a component derived from at least one plant selected from the group consisting of Salacia genus plants, touchi and mulberry, and a lipid synthesis inhibitor component, preferably, at least one selected from the group consisting of soybean peptide, marine animal peptide, and sesame lignin, and also provides a food product including the composition.
    Type: Application
    Filed: February 20, 2014
    Publication date: July 3, 2014
    Applicant: FUJIFILM Corporation
    Inventors: Yuriko ODA, Fumitaka Ueda
  • Patent number: 8747836
    Abstract: The present invention provides an agent for inhibition of alcoholic hepatopathy comprising cells of a strain belonging to Lactobacillus brevis, or treated product thereof as an active ingredient. The agent for inhibition of alcoholic hepatopathy of the present invention is safe for living body and can be used as a component in foods and beverages.
    Type: Grant
    Filed: January 14, 2009
    Date of Patent: June 10, 2014
    Assignee: Sapporo Breweries Limited
    Inventors: Syuichi Segawa, Yoshihisa Wakita
  • Publication number: 20140141976
    Abstract: Biocontrol agents are provided, which protect plant and plant material from pests and pathogens, and promote the growth of plants. Also provided are compositions comprising the same, methods for protecting plant and plant material and promoting growth in plants, and uses of said biocontrol agent in the preparation of a pesticidal composition and a growth-promoting composition.
    Type: Application
    Filed: February 5, 2014
    Publication date: May 22, 2014
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Marganit Levy, Aviva Gafni
  • Publication number: 20140140984
    Abstract: The present invention relates to a composition for preventing or treating respiratory diseases, and more particularly, to a pharmaceutical composition, and to a health food, comprising extracts of herbal mixtures or fermented products thereof having lactic acid bacteria as effective ingredients for preventing or treating respiratory diseases, wherein the herbal mixtures comprise: Sophora flavascens, Radix glycyrrhizae, Flos Lonicerae, Angelicae Gigantis radix, Aralia continentalis, Inula helenium, Saposhnikoviae radix, Zizyphus spinosa, Houttuynia cordata, Forsythiae fructus, Arctium lappa, Herba epimedii, ginseng, Lithospermi radix, Sanguisorbae radix, Cnidii rhizoma, Scrophulariae radix, and Polygoni cuspidati radix.
    Type: Application
    Filed: May 30, 2012
    Publication date: May 22, 2014
    Applicant: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Jin Yeul Ma, Dong Seon Kim, Min Cheol Yang, Jong Hyun Yoon